MedInvest, a leading healthcare, biotech, and medtech media and conference company, announced that it will host its semi-annual Biotech and Pharma Investor Conference in New York City, NY on September 18-19, 2024.  The National Institutes of Health and O'Melveny Law Firm will be presenting sponsors of the event.

 

The conference is expected to attract 125+ investors spanning venture and public funds, family offices, strategics, and government and non-profit grant making entities. The two-day event will consist of half a dozen talks by KOLs and investor panels.

 

During, before and after the conference for two weeks, meetings will be facilitated both in person and virtually via the conference’s partnering system.